Search Results for: MRNS

Top Analyst Upgrades and Downgrades: DowDuPont, Electronic Arts, Estee Lauder, Exxon, Generac, Match, Nasdaq, Novartis, PayPal, Snap, Vishay and More

Stocks were looking for direction on Wednesday after Tuesday's solid gains. The Dow Jones industrial average is now well over 2,500 points above its lows from the start of January. ...
Read Full Story »

How Marinus Pharma Is Capitalizing on Its Depression Study Success

Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) shares backed off on Wednesday when the firm announced that it would be conducting a secondary offering. The company is capitalizing on its success earlier ...
Read Full Story »

Marinus Scores Big With Midstage Depression Study

Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) shares made a handy gain on Monday after the company announced positive results from its midstage trial in women with postpartum depression. Specifically, the firm ...
Read Full Story »

Marinus Pharma Wins Big With Mid-Stage Epilepsy Study

Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) saw its shares make a huge gain to kick off the week after the firm announced top-line results from its mid-stage study in patients with ...
Read Full Story »
Female patient on gurney

Why This Seizure Drug Matters So Much for Marinus Pharma

Marinus Pharmaceuticals, Inc. (NASDAQ: MRNS) saw its shares climb on Monday after the company reported positive preliminary results from a mid-stage trial. Specifically the data came from Mirna’s Phase 2 ...
Read Full Story »
reprimand

6 Companies That Destroyed Shareholders Last Week

After the Federal Reserve announced that interest rates would not be raised on Wednesday, many would expect that the market would turn itself around after having about four down days in ...
Read Full Story »
approve disapprove

Top Analyst Upgrades and Downgrades: Alaska Air, Altria, GoDaddy, GoPro, LinkedIn, Navistar and More

Stocks were indicated lower on Tuesday ahead of this week's Federal Open Market Committee (FOMC) meeting and decision on interest rates. Long-term bund yields in Germany also just went negative for ...
Read Full Story »
clinical trials

Why Marinus Pharmaceuticals Shares Are Sliding

Shares of Marinus Pharmaceuticals Inc. (NASDAQ: MRNS) tumbled Monday morning after the company gave an update on top-line results from its Phase 3 clinical trial in adults with drug-resistant focal ...
Read Full Story »
buy sell stocks

14 Fresh Analyst Stocks Called to Rise 50% to 100%

Stocks have become quite choppy going into the end of 2015, and the strength of the bull market's nearly seven-year tenure is now up for question. Still, despite Wall Street ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: AK Steel, CVS, Micron, Nike, Oracle, Pandora, Sunrun, US Steel and Many More

Stocks were indicated higher yet again on Thursday, even after the Federal Reserve finally raised interest rates. The trend that has been in place for more than four years now ...
Read Full Story »
IPO

IPO Week Ahead: GE Spins Out Synchrony in a Whirl of 22 IPOs

We have counted 22 initial public offerings (IPOs) on the schedule for this week, including just two holdovers from last week. Of the dozen companies that actually made it to ...
Read Full Story »